REQUEST A DEMO
Total
USD $0.00
Search more companies

Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company) (Iran)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Razak Laboratories Company Public Joint Stock Profile Updated: February 25, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company) is an enterprise based in Iran. Its main office is in Tehran. It operates in the Pharmaceutical Preparation Manufacturing sector. It was established on April 04, 1964. Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company) currently employs 458 (2025) people. From the latest financial highlights, Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company) reported a net sales revenue increase of 56.88% in Q2C2026. There was a total growth of 118.61% in Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company)’s total assets over the same period. The enterprise’s net profit margin decreased by 8.37% in 2026.

Headquarters
Km 10,Lashgari Expy, In Front Of Pars Minoo Company, Po Box 13185-1671
Tehran; Tehran; Postal Code: 1389736615

Contact Details: Purchase the Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company) report to view the information.

Website: http://www.razakpharma.com

Basic Information
Total Employees:
Purchase the Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company) report to view the information.
Outstanding Shares:
Purchase the Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company) report to view the information.
Financial Auditors:
Purchase the Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company) report to view the information.
Incorporation Date:
April 04, 1964
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
4%
Purchase this report to view the information.
3%
Purchase this report to view the information.
2%
Purchase this report to view the information.
2%
Subsidiaries
Zagros Pharmed Pars Pharmaceuticals Company Public Joint Stock
47.46%
Zahravi Pharmaceutical Company Public Joint Stock
16.4%
Shahid Ghazi Pharmaceutical Company Public Joint Stock
10.9%
Company Performance
Financial values in the chart are available after Razak Laboratories Company Public Joint Stock (Razak Pharmaceutical Laboratories Company Public Shareholding Company) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Net sales revenue
56.88%
Total Operating Revenue
59.96%
Operating Profit
10.35%
EBITDA
10.71%
Net Profit/Loss for the Period
14.93%
Total Assets
118.61%
Total Equity
283.27%
Operating Profit Margin
-14.89%
Net Profit Margin
-8.37%
Return on Equity (ROE)
-25.68%
Debt / Equity
-94960%
Quick Ratio
-37.3%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?